07:42 AM EDT, 05/22/2026 (MT Newswires) -- Futu ( FUTU ) and UP Fintech ( TIGR ) shares were down 38% and 37%, respectively, in Friday premarket activity after China's securities regulator said the companies could face penalties for operating in mainland China without licenses.

NervGen Pharma ( NGEN ) stock was 33% lower after the company priced an offering of 24 million shares and warrants.

Aditxt ( ADTX ) shares were down 26%, extending losses from the previous session.

Liminatus Pharma ( LIMN ) stock was 22% lower after the company said it received a delisting notice from Nasdaq.